Vicore Pharma Holding AB (publ) (VCRE)

NASDAQ: VCRE · Real-Time Price · USD

11.28

+0.22 (1.99%)

At close: Jul 28, 2026, 4:00 PM EDT

11.45

+0.17 (1.51%)

After-hours: Jul 28, 2026, 4:10 PM EDT

Vicore Pharma Holding AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	377.42	578.15	1,156	333.62	256.8	294.2
Short-Term Investments	682.37	588.59	0	149.15	4.94	77.28
Cash & Short-Term Investments	1,060	1,167	1,156	482.77	261.74	371.48
Cash Growth	1.05%	0.93%	139.45%	84.44%	-29.54%	0%
Other Receivables	4.1	13.8	14.39	3.13	2.18	1.42
Total Trade Receivables	4.1	13.8	14.39	3.13	2.18	1.42
Other Current Assets	10.36	36.38	25.19	9.7	5.87	5.03
Total Current Assets	1,074	1,217	1,196	495.6	269.79	377.93
Net Property, Plant & Equipment	-	-	-	0.03	0.05	0.08
Other Intangible Assets	-	0	0	2.22	68.1	67.43
Long-Term Investments	-	-	-	0	0	5.41
Other Long-Term Assets	3.02	1.71	0	0	0.06	0.32
Total Assets	1,077	1,219	1,196	497.84	338.01	451.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	34.1	39.47	29.97	17.92	23.5	23.98
Accrued Expenses	48.11	65.8	15.75	14.65	18.22	40.14
Unearned Revenue	-	-	-	0	0.07	0
Other Current Liabilities	2.46	13.16	19.97	8.4	4.64	1.6
Total Current Liabilities	84.66	118.43	65.69	40.96	46.42	65.72
Other Long-Term Liabilities	1.69	4.74	0.56	1.49	2.51	2.13
Total Long-Term Liabilities	1.69	4.74	0.56	1.49	2.51	2.13
Total Liabilities	86.35	123.18	66.25	42.45	48.92	67.85

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	-	140.76	117.29	55.86	40.92	35.88
Additional Paid-in Capital	-	2,876	2,454	1,674	1,211	1,022
Retained Earnings	-	-1,921	-1,442	-1,274	-962.65	-674.23
Shareholders' Equity	990.91	1,095	1,129	455.39	289.08	383.32
Total Liabilities & Equity	1,077	1,219	1,196	497.84	338.01	451.17

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	1,060	1,167	1,156	482.77	261.74	371.48
Net Cash Growth	1.05%	0.93%	139.45%	84.44%	-29.54%	0%
Net Cash Per Share	4.21	4.86	8.45	5.00	3.63	5.33
Book Value	990.91	1,095	1,129	455.39	289.08	383.32
Book Value Per Share	3.94	4.57	8.25	4.72	4.00	5.50
Tangible Book Value	990.91	1,095	1,129	453.17	220.98	315.89
Tangible Book Value Per Share	3.94	4.57	8.25	4.69	3.06	4.53